Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.

ABSTRACT:

Background

Clinical trials have demonstrated a mortality benefit from lung cancer screening by low-dose CT (LDCT) in current or past tobacco smokers who meet criteria. Potential harms of screening mostly relate to downstream evaluation of abnormal screens. Few data exist on the rates outside of clinical trials of imaging and diagnostic procedures following screening LDCT. We describe rates in the community setting of follow-up imaging and diagnostic procedures after screening LDCT.

Methods

We used Clinformatics Data Mart national database to identify enrollees age 55 to 80 year who underwent screening LDCT from January 1, 2016, to December 31, 2016. We assessed rates of follow-up imaging (diagnostic chest CT scan, MRI, and PET) and follow-up procedures (bronchoscopy, percuta

SUBMITTER: Nishi SPE 

PROVIDER: S-EPMC7005377 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature